REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,215 | -99.4% | 152,290 | +293.8% | 0.04% | +300.0% |
Q3 2022 | $763,000 | +0.9% | 38,676 | -0.2% | 0.01% | +11.1% |
Q2 2022 | $756,000 | +33.6% | 38,766 | +74.7% | 0.01% | +28.6% |
Q1 2022 | $566,000 | +120.2% | 22,187 | +117.0% | 0.01% | +133.3% |
Q4 2021 | $257,000 | -35.3% | 10,226 | +18.1% | 0.00% | -50.0% |
Q1 2021 | $397,000 | -27.6% | 8,662 | -37.4% | 0.01% | +20.0% |
Q4 2020 | $548,000 | – | 13,834 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nextech Invest Ltd. | 4,839,529 | $104,824,198 | 43.76% |
Column Group LLC | 4,577,840 | $99,156,014 | 35.85% |
Mass General Brigham, Inc | 338,191 | $7,325 | 5.71% |
Boxer Capital, LLC | 4,684,264 | $101,461 | 4.98% |
BVF INC/IL | 4,955,588 | $107,338,036 | 3.92% |
DAFNA Capital Management LLC | 575,785 | $12,471,503 | 3.74% |
EcoR1 Capital, LLC | 5,352,183 | $115,928,284 | 3.73% |
Casdin Capital, LLC | 1,810,000 | $39,204,600 | 3.23% |
Artal Group S.A. | 2,070,988 | $44,858 | 2.66% |
Integral Health Asset Management, LLC | 345,000 | $7,472,700 | 1.50% |